|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Lee Chih Wen | Su Muh Hwan | Su Muh Hwan | (02)2764-0826 | 84 CHUNG SHAN RD.,CHUNG SHAN VILLAGETUNG-SHAN SHINE , I-LAN 269 , TAIWAN. | 2014/10/28 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Scope of Business: (1) I101090 Food Consultancy (2) IC01010 Pharmaceuticals Examining Services (3) IG01010 Biotechnology Services (4) F108021 Wholesale of Drugs and Medicines (5) F601010 Intellectual Property (6) ZZ99999 To carry on the businesses which are not prohibited or restricted by law except for services licensed under approval. Vision SynCore actively cooperates with Asian countries to obtain the authorities to the sole agency to build the new drug development network of multi-national research sites. With the help from the global partners, we are committed to evergreen development. |
Market Information ( 2024/05/02 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
13.682 | 48.10 | 46.70 | 47.45 | 0.35 | 20 | .00 | N/A | N/A | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/05/03) |
TPEx measures adopted (2024/05/03) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |